Pharmaceutical Preparations · DE · CIK 1398733
Aquestive develops and manufactures innovative medicines using proprietary delivery technologies for improved patient outcomes
Comparable business profile · signals at a glance
In the 90 days to Mar 10, 2026: 7 sold $1.7M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Barber DanielPresident and CEO | Sell | 180,677 | $4.17 | $753K |
| Mar 10, 2026 | Toth A Ernest JrChief Financial Officer | Sell | 58,254 | $4.17 | $243K |
| Mar 10, 2026 | Jung CassieChief Operating Officer | Sell | 45,791 | $4.17 | $191K |
| Mar 10, 2026 | Braender Lori JChief Legal Officer | Sell | 40,102 | $4.17 | $167K |
| Mar 10, 2026 | Boyd Peter E.Chief People Officer | Sell | 29,814 | $4.17 | $124K |
| Mar 10, 2026 | Cioffi MelinaSVP, Regulatory Affairs | Sell | 25,311 | $4.17 | $106K |
| Mar 10, 2026 | Korczynski SherryChief Commercial Officer | Sell | 15,741 | $4.17 | $66K |
| Oct 15, 2025 | Jung CassieChief Operating Officer | Sell | 67,575 | $7.01 | $474K |
| Oct 15, 2025 | Kraus Carl NChief Medical Officer | Sell | 20,272 | $7.00 | $142K |
| Oct 15, 2025 | Boyd Peter E.See Remarks | Sell | 10,000 | $7.00 | $70K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.